Skip to main content

Table 1 Clinical characteristics of the study groups at visit 0 and visit 1

From: Predictive value of dynamic renal resistive index (drin) for renal outcome in type 2 diabetes and essential hypertension: a prospective study

  EH (n = 43) visit 0 EH (n = 43) visit 1 T2DM (n = 27) visit 0 T2DM (n = 27) visit 1
Age (years) 51.7 ± 8.0 - 60.0 ± 10.5* -
Men (n,%) 32 (74 %) - 14 (52 %) -
Smokers (n,%) 9 (21 %) - 5 (19 %) -
BMI (Kg/m2) 26.6 (24.6-31.1) 28.4 (25.1-30.1) 30.0 (27.9-36.1)* 29.2 (27.2-35.1)
Brachial systolic BP (mmHg) 142.7 ± 9.9 144.5 ± 17.9 139.8 ± 14.5 141.2 ± 10.7
Brachial diastolic BP (mmHg) 86.1 ± 8.1 86.9 ± 11.8 78.7 ± 8.8* 73.1 ± 9.4
Brachial PP (mmHg) 56.6 ± 8.1 57.6 ± 11.1 61.1 ± 16.6 68.2 ± 13.7
Mean BP (mmHg) 105.7 ± 7.9 107.1 ± 11.5 100.6 ± 7.9* 96.6 ± 7.6
Aortic systolic BP (mmHg) 131.5 ± 11.8 132.4 ± 13.0 128.6 ± 17.2 126.9 ± 10.1
Aortic PP (mmHg) 47.2 ± 13.7 45.2 ± 8.6 51.4 ± 16.4 52.9 ± 13.5
Heart rate (bpm) 65.8 ± 10.5 71.1 ± 10.4# 68.5 ± 12.6 68.6 ± 11.8
Fasting plasma glucose (mg/dl) 90 (86–95) 90 (86–96) 140 (119–183)* 114 (107–132)#
Hb1Ac (%) 5.2 (5.0-5.7) 5.4 (5.0-6.4) 6.9 (6.4-7.4)* 6.4 (6.1-7.1) #
Total cholesterol (mg/dl) 209 ± 34 206 ± 39 227 ± 53 183 ± 38#
LDL-cholesterol (mg/dl) 137 ± 36 127 ± 36 131 ± 57 107 ± 31
HDL-cholesterol (mg/dl) 50 ± 14 53 ± 12 50 ± 17 52 ± 13
Triglycerides (mg/dl) 104 (71–174) 108 (73–162) 164 (102–247) 131 (91–159)
Serum creatinine (mg/dl) 0.90 ± 0.17 0.91 ± 0.18 0.86 ± 0.21 0.85 ± 0.19
eGFR (ml/min/1.73 m2) 91.1 ± 13.7 86.9 ± 13.4 86.3 ± 15.1 84.4 ± 14.2
UACR (mg/g) 2.0 (0–5.9) 9.3 (5.7-18.4) # 6.6 (1.6-15.5)* 10.7 (3.8-44.8) #
Nitrotyrosine (μmol/l ) 9.8 ± 1.4 12.2 ± 3.2 # 13.1 ± 2.5* 11.9 ± 3.4
  1. *p < 0.05 vs EH group
  2. #p < 0.05 vs Visit 0